BioCryst Pharmaceuticals, Inc.
(NASDAQ : BCRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-2.26%275.511.4%$809.99m
AMGNAmgen, Inc.
-0.06%218.101.3%$494.73m
CELGCelgene Corp.
-0.46%109.901.3%$454.59m
GILDGilead Sciences, Inc.
0.32%63.541.0%$380.31m
ILMNIllumina, Inc.
-0.02%298.173.5%$303.17m
VRTXVertex Pharmaceuticals, Inc.
-1.02%204.991.9%$296.73m
REGNRegeneron Pharmaceuticals, Inc.
-2.35%340.112.6%$258.40m
EXASEXACT Sciences Corp.
1.46%79.3924.0%$197.71m
ALXNAlexion Pharmaceuticals, Inc.
-1.41%105.622.0%$180.60m
SGENSeattle Genetics, Inc.
-0.14%112.056.1%$131.36m
BMRNBioMarin Pharmaceutical, Inc.
-0.33%75.894.3%$115.86m
SRPTSarepta Therapeutics, Inc.
-2.25%98.7314.6%$112.84m
AAgilent Technologies, Inc.
-0.40%76.851.6%$100.70m
MRTXMirati Therapeutics, Inc.
1.29%102.032.3%$87.73m
NBIXNeurocrine Biosciences, Inc.
-1.18%109.605.0%$84.66m

Company Profile

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.